Genprex Sale Purchase Of Stock vs Begin Period Cash Flow Analysis

GNPX Stock

USD 1.16 0.10 9.43%

Genprex financial indicator trend analysis is much more than just examining Genprex latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genprex is a good investment. Please check the relationship between Genprex Sale Purchase Of Stock and its Begin Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Sale Purchase Of Stock vs Begin Period Cash Flow

Sale Purchase Of Stock vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genprex Sale Purchase Of Stock account and Begin Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.

The correlation between Genprex's Sale Purchase Of Stock and Begin Period Cash Flow is 0.73. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Genprex, assuming nothing else is changed. The correlation between historical values of Genprex's Sale Purchase Of Stock and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Genprex are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Sale Purchase Of Stock i.e., Genprex's Sale Purchase Of Stock and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.73

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Sale Purchase Of Stock

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Genprex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genprex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.Issuance Of Capital Stock is likely to rise to about 12.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 9.2 M in 2024.

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	22.5K	25.6K	17.7K	17.4K
Interest Income	5.1K	90.1K	231.0K	242.6K

Reconciled Depreciation Interest Income

Genprex fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Receivables
Total Assets		0.43	0.5	1.0	0.78	0.75	-0.99	-0.62	0.46	1.0	0.74	0.68	0.14	1.0	0.79	-0.74	0.8	0.8	0.81	0.5	0.7	1.0	0.77	0.88	0.72	-0.03
Other Current Liab	0.43		0.96	0.38	0.82	0.1	-0.33	-0.88	0.76	0.39	0.79	0.85	-0.01	0.39	0.78	-0.61	0.77	0.69	0.76	0.96	0.66	0.38	0.75	0.32	0.73	0.33
Total Current Liabilities	0.5	0.96		0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.83	0.82	1.0	0.77	0.45	0.81	0.29	0.84	0.08
Total Stockholder Equity	1.0	0.38	0.45		0.74	0.76	-0.99	-0.58	0.42	1.0	0.69	0.64	0.15	1.0	0.76	-0.71	0.76	0.78	0.77	0.45	0.67	1.0	0.73	0.88	0.68	-0.05
Net Tangible Assets	0.78	0.82	0.9	0.74		0.41	-0.69	-0.97	0.82	0.75	0.85	0.88	-0.04	0.75	0.97	-0.83	0.98	0.94	0.93	0.9	0.84	0.75	0.89	0.52	0.9	-0.05
Property Plant And Equipment Net	0.75	0.1	0.19	0.76	0.41		-0.77	-0.35	0.27	0.75	0.45	0.31	0.19	0.75	0.57	-0.7	0.55	0.52	0.57	0.19	0.72	0.76	0.66	0.84	0.65	-0.18
Net Debt	-0.99	-0.33	-0.38	-0.99	-0.69	-0.77		0.52	-0.35	-0.99	-0.69	-0.61	-0.15	-0.99	-0.71	0.66	-0.71	-0.73	-0.76	-0.38	-0.62	-0.99	-0.71	-0.9	-0.63	0.0
Retained Earnings	-0.62	-0.88	-0.96	-0.58	-0.97	-0.35	0.52		-0.88	-0.58	-0.82	-0.87	0.09	-0.58	-0.95	0.84	-0.95	-0.9	-0.9	-0.96	-0.87	-0.58	-0.9	-0.4	-0.93	0.05
Accounts Payable	0.46	0.76	0.89	0.42	0.82	0.27	-0.35	-0.88		0.43	0.73	0.81	0.02	0.43	0.82	-0.68	0.81	0.86	0.72	0.89	0.76	0.42	0.75	0.18	0.82	-0.31
Cash	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43		0.71	0.65	0.13	1.0	0.76	-0.7	0.76	0.78	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Non Current Assets Total	0.74	0.79	0.83	0.69	0.85	0.45	-0.69	-0.82	0.73	0.71		0.96	-0.07	0.71	0.81	-0.72	0.8	0.85	0.91	0.83	0.7	0.69	0.85	0.62	0.77	0.19
Non Currrent Assets Other	0.68	0.85	0.9	0.64	0.88	0.31	-0.61	-0.87	0.81	0.65	0.96		-0.13	0.65	0.82	-0.69	0.81	0.88	0.84	0.9	0.68	0.63	0.77	0.49	0.77	0.15
Other Assets	0.14	-0.01	-0.09	0.15	-0.04	0.19	-0.15	0.09	0.02	0.13	-0.07	-0.13		0.13	0.13	-0.04	0.05	-0.11	0.0	-0.09	0.04	0.16	0.1	0.28	-0.02	-0.12
Cash And Short Term Investments	1.0	0.39	0.45	1.0	0.75	0.75	-0.99	-0.58	0.43	1.0	0.71	0.65	0.13		0.76	-0.7	0.76	0.78	0.77	0.45	0.67	1.0	0.73	0.87	0.68	-0.03
Common Stock Total Equity	0.79	0.78	0.87	0.76	0.97	0.57	-0.71	-0.95	0.82	0.76	0.81	0.82	0.13	0.76		-0.9	1.0	0.92	0.93	0.87	0.93	0.77	0.95	0.61	0.96	-0.11
Common Stock Shares Outstanding	-0.74	-0.61	-0.72	-0.71	-0.83	-0.7	0.66	0.84	-0.68	-0.7	-0.72	-0.69	-0.04	-0.7	-0.9		-0.9	-0.8	-0.86	-0.72	-0.94	-0.72	-0.91	-0.65	-0.94	0.15
Capital Surpluse	0.8	0.77	0.86	0.76	0.98	0.55	-0.71	-0.95	0.81	0.76	0.8	0.81	0.05	0.76	1.0	-0.9		0.92	0.94	0.86	0.93	0.77	0.94	0.59	0.96	-0.12
Other Current Assets	0.8	0.69	0.83	0.78	0.94	0.52	-0.73	-0.9	0.86	0.78	0.85	0.88	-0.11	0.78	0.92	-0.8	0.92		0.89	0.83	0.83	0.77	0.85	0.51	0.89	-0.23
Other Stockholder Equity	0.81	0.76	0.82	0.77	0.93	0.57	-0.76	-0.9	0.72	0.77	0.91	0.84	0.0	0.77	0.93	-0.86	0.94	0.89		0.82	0.86	0.77	0.97	0.67	0.9	0.03
Total Liab	0.5	0.96	1.0	0.45	0.9	0.19	-0.38	-0.96	0.89	0.45	0.83	0.9	-0.09	0.45	0.87	-0.72	0.86	0.83	0.82		0.77	0.45	0.81	0.29	0.84	0.08
Property Plant And Equipment Gross	0.7	0.66	0.77	0.67	0.84	0.72	-0.62	-0.87	0.76	0.67	0.7	0.68	0.04	0.67	0.93	-0.94	0.93	0.83	0.86	0.77		0.68	0.94	0.6	0.99	-0.17
Total Current Assets	1.0	0.38	0.45	1.0	0.75	0.76	-0.99	-0.58	0.42	1.0	0.69	0.63	0.16	1.0	0.77	-0.72	0.77	0.77	0.77	0.45	0.68		0.74	0.88	0.69	-0.05
Intangible Assets	0.77	0.75	0.81	0.73	0.89	0.66	-0.71	-0.9	0.75	0.73	0.85	0.77	0.1	0.73	0.95	-0.91	0.94	0.85	0.97	0.81	0.94	0.74		0.68	0.95	-0.03
Common Stock	0.88	0.32	0.29	0.88	0.52	0.84	-0.9	-0.4	0.18	0.87	0.62	0.49	0.28	0.87	0.61	-0.65	0.59	0.51	0.67	0.29	0.6	0.88	0.68		0.58	0.25
Property Plant Equipment	0.72	0.73	0.84	0.68	0.9	0.65	-0.63	-0.93	0.82	0.68	0.77	0.77	-0.02	0.68	0.96	-0.94	0.96	0.89	0.9	0.84	0.99	0.69	0.95	0.58		-0.14
Net Receivables	-0.03	0.33	0.08	-0.05	-0.05	-0.18	0.0	0.05	-0.31	-0.03	0.19	0.15	-0.12	-0.03	-0.11	0.15	-0.12	-0.23	0.03	0.08	-0.17	-0.05	-0.03	0.25	-0.14

Click cells to compare fundamentals

Genprex Account Relationship Matchups

Genprex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Other Current Liab	74.4K	257.8K	612.1K	2.4M	1.9M	1.9M
Total Current Liabilities	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Total Stockholder Equity	3.0M	30.9M	41.3M	22.3M	7.4M	14.2M
Net Tangible Assets	8.5M	2.5M	30.3M	40.6M	46.7M	49.1M
Property Plant And Equipment Net	44.7K	39.4K	48.6K	23.0K	7.9K	7.5K
Net Debt	(2.0M)	(27.3M)	(38.6M)	(21.0M)	(6.7M)	(7.1M)
Retained Earnings	(40.5M)	(58.4M)	(78.0M)	(102.8M)	(133.7M)	(127.0M)
Accounts Payable	436.3K	193.0K	973.2K	442.9K	1.4M	1.5M
Cash	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Non Current Assets Total	557.6K	651.8K	3.7M	3.6M	3.1M	1.7M
Non Currrent Assets Other	21.7K	10.7K	3.0M	2.9M	2.4M	2.5M
Other Assets	21.7K	612.4K	0.0	1.0	0.9	0.86
Cash And Short Term Investments	2.0M	27.3M	38.6M	21.0M	6.7M	13.0M
Common Stock Total Equity	11.7K	15.2K	19.3K	43.1K	49.6K	52.1K
Common Stock Shares Outstanding	400.7K	888.1K	1.2M	1.2M	1.4M	1.3M
Liabilities And Stockholders Equity	3.5M	31.4M	42.9M	25.1M	10.7M	15.4M
Capital Surpluse	17.9M	38.7M	43.5M	89.3M	102.7M	107.8M
Other Current Assets	171.7K	384.7K	1.0M	484.2K	794.1K	833.8K
Other Stockholder Equity	43.5M	89.3M	120.3M	125.1M	141.1M	73.6M
Total Liab	510.7K	450.7K	1.6M	2.8M	3.3M	3.4M
Property Plant And Equipment Gross	7.8K	24.4K	44.7K	39.4K	45.4K	47.6K
Total Current Assets	3.0M	30.7M	39.1M	21.5M	7.5M	13.8M
Intangible Assets	491.2K	601.6K	642.4K	702.1K	773.5K	523.9K
Common Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K
Property Plant Equipment	24.4K	44.7K	39.4K	48.6K	55.9K	58.7K
Net Receivables	8.8K	9.3K	655.0	127.0	0.0	34.9K
Net Invested Capital	3.0M	30.9M	41.3M	22.3M	7.4M	7.0M
Net Working Capital	2.5M	30.3M	37.6M	18.7M	4.3M	4.1M
Capital Stock	19.3K	43.1K	47.9K	48.1K	1.5K	1.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Genprex Stock Analysis

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genprex Sale Purchase Of Stock vs Begin Period Cash Flow Analysis

Sale Purchase Of Stock vs Begin Period Cash Flow

Sale Purchase Of Stock vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Begin Period Cash Flow

Genprex fundamental ratios Correlations

Genprex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Genprex fundamental ratios Accounts

Also Currently Popular

Additional Tools for Genprex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Retained Earnings	- 0.97	Net Tangible Assets